Sunday May 5, 2024 | Last Update: May 5, 2024 EDT
Merck KGaA, a German drugs and chemicals maker, is considering the sale of its allergy business Allergopharma, people with knowledge of the matter told Bloomberg. The German company is looking to reduce its debt following the $17 billion acquisition of Sigma-Aldrich Corp.
Read more >>
Just In
Most Read
1
2
3
4
5